Pseudomonas siderophores in the sputum of patients with cystic fibrosis. 2011

Lois W Martin, and David W Reid, and Katrina J Sharples, and Iain L Lamont
Department of Biochemistry, University of Otago, Dunedin, New Zealand.

The lungs of patients with cystic fibrosis become chronically infected with the bacterium Pseudomonas aeruginosa, which heralds progressive lung damage and a decline in health. Iron is a crucial micronutrient for bacteria and its acquisition is a key factor in infection. P. aeruginosa can acquire this element by secreting pyoverdine and pyochelin, iron-chelating compounds (siderophores) that scavenge iron and deliver it to the bacteria. Siderophore-mediated iron uptake is generally considered a key factor in the ability of P. aeruginosa to cause infection. We have investigated the amounts of pyoverdine in 148 sputum samples from 36 cystic fibrosis patients (30 infected with P. aeruginosa and 6 as negative controls). Pyoverdine was present in 93 samples in concentrations between 0.30 and 51 μM (median 4.6 μM) and there was a strong association between the amount of pyoverdine and the number of P. aeruginosa present. However, pyoverdine was not present, or below the limits of detection (~0.3 μM), in 21 sputum samples that contained P. aeruginosa. Pyochelin was also absent, or below the limits of detection (~1 μM), in samples from P. aeruginosa-infected patients with little or no detectable pyoverdine. Our data show that pyoverdine is an important iron-scavenging molecule for P. aeruginosa in many cystic fibrosis patients, but other P. aeruginosa iron-uptake systems must be active in some patients to satisfy the bacterial need for iron.

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D008297 Male Males
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Lois W Martin, and David W Reid, and Katrina J Sharples, and Iain L Lamont
July 1994, Pathology,
Lois W Martin, and David W Reid, and Katrina J Sharples, and Iain L Lamont
May 1987, Lancet (London, England),
Lois W Martin, and David W Reid, and Katrina J Sharples, and Iain L Lamont
June 1985, Oral surgery, oral medicine, and oral pathology,
Lois W Martin, and David W Reid, and Katrina J Sharples, and Iain L Lamont
July 2020, Journal of visualized experiments : JoVE,
Lois W Martin, and David W Reid, and Katrina J Sharples, and Iain L Lamont
January 1983, Annali Sclavo; rivista di microbiologia e di immunologia,
Lois W Martin, and David W Reid, and Katrina J Sharples, and Iain L Lamont
January 2019, Respiratory medicine,
Lois W Martin, and David W Reid, and Katrina J Sharples, and Iain L Lamont
November 1994, Lancet (London, England),
Lois W Martin, and David W Reid, and Katrina J Sharples, and Iain L Lamont
March 2015, Proceedings of the National Academy of Sciences of the United States of America,
Lois W Martin, and David W Reid, and Katrina J Sharples, and Iain L Lamont
October 1997, Medical microbiology and immunology,
Lois W Martin, and David W Reid, and Katrina J Sharples, and Iain L Lamont
April 1986, European journal of clinical investigation,
Copied contents to your clipboard!